{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:57:18Z","timestamp":1792112238930,"version":"4.4.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Antipsychotic medications are frequently prescribed in acute care for clinical indications other than primary psychiatric disorders such as delirium. Unfortunately, they are commonly continued at hospital discharge and at follow-ups thereafter. The objective of this scoping review was to characterize antipsychotic medication prescribing practices, to describe healthcare professional perceptions on antipsychotic prescribing and deprescribing practices, and to report on antipsychotic deprescribing strategies within acute care.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We searched MEDLINE, EMBASE, PsycINFO, CINAHL, and Web of Science databases from inception date to July 3, 2021 for published primary research studies reporting on antipsychotic medication prescribing and deprescribing practices, and perceptions on those practices within acute care. We included all study designs excluding protocols, editorials, opinion pieces, and systematic or scoping reviews. Two reviewers screened and abstracted data independently and in duplicate. The protocol was registered on Open Science Framework prior to data abstraction (10.17605\/OSF.IO\/W635Z).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of 4528 studies screened, we included 80 studies. Healthcare professionals across all acute care settings (intensive care, inpatient, emergency department) perceived prescribing haloperidol (<jats:italic>n<\/jats:italic>\u2009=\u200936\/36, 100%) most frequently, while measured prescribing practices reported common quetiapine prescribing (<jats:italic>n<\/jats:italic>\u2009=\u200926\/36, 76%). Indications for antipsychotic prescribing were delirium (<jats:italic>n<\/jats:italic>\u2009=\u200948\/69, 70%) and agitation (<jats:italic>n<\/jats:italic>\u2009=\u200920\/69, 29%). Quetiapine (<jats:italic>n<\/jats:italic>\u2009=\u200918\/18, 100%) was most frequently prescribed at hospital discharge. Three studies reported in-hospital antipsychotic deprescribing strategies focused on pharmacist-driven deprescribing authority, handoff tools, and educational sessions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Perceived antipsychotic prescribing practices differed from measured prescribing practices in acute care settings. Few in-hospital deprescribing strategies were described. Ongoing evaluation of antipsychotic deprescribing strategies are needed to evaluate their efficacy and risk.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12913-022-08650-7","type":"journal-article","created":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T13:02:38Z","timestamp":1666357358000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A scoping review of perceptions from healthcare professionals on antipsychotic prescribing practices in acute care settings"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2995-5527","authenticated-orcid":false,"given":"Natalia","family":"Jaworska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephana J.","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla D.","family":"Krewulak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zara","family":"Stelfox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Niven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahinoor","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa D.","family":"Burry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten M.","family":"Fiest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,21]]},"reference":[{"issue":"2","key":"8650_CR1","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1017\/S1041610209990986","volume":"22","author":"I Briskman","year":"2010","unstructured":"Briskman I, Dubinski R, Barak Y. Treating delirium in a general hospital: a descriptive study of prescribing patterns and outcomes. Int Psychogeriatr. 2010;22(2):328\u201331.","journal-title":"Int Psychogeriatr"},{"key":"8650_CR2","first-page":"CD011749","volume":"9","author":"L Burry","year":"2019","unstructured":"Burry L, Hutton B, Williamson DR, Mehta S, Adhikari NK, Cheng W, et al. Pharmacological interventions for the treatment of delirium in critically ill adults. Cochrane Database Syst Rev. 2019;9:CD011749.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"8650_CR3","first-page":"107","volume":"69","author":"ZPM Thiboutot","year":"2016","unstructured":"Thiboutot ZPM, Williamson DR, Rose L, Mehta S, Gueneette MD, Cook D, Burry L. Antipsychotic drug use and screening for delirium in mechanically ventilated patients in Canadian intensive care units: an observational study. Can J Hosp Pharm. 2016;69(2):107\u201313.","journal-title":"Can J Hosp Pharm"},{"issue":"23","key":"8650_CR4","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.2174\/1381612821666150619092903","volume":"21","author":"L Carton","year":"2015","unstructured":"Carton L, Cottencin O, Lapeyre-Mestre M, Geoffroy PA, Favre J, Simon N, et al. Off-label prescribing of antipsychotics in adults, children and elderly individuals: a systematic review of recent prescription trends. Curr Pharm Des. 2015;21(23):3280\u201397.","journal-title":"Curr Pharm Des"},{"issue":"7","key":"8650_CR5","doi-asserted-by":"publisher","first-page":"485","DOI":"10.7326\/M19-1860","volume":"171","author":"R Nikooie","year":"2019","unstructured":"Nikooie R, Neufeld KJ, Oh ES, Wilson LM, Zhang A, Robinson KA, et al. Antipsychotics for treating delirium in hospitalized adults: a systematic review. Ann Intern Med. 2019;171(7):485\u201395.","journal-title":"Ann Intern Med"},{"issue":"7","key":"8650_CR6","doi-asserted-by":"publisher","first-page":"474","DOI":"10.7326\/M19-1859","volume":"171","author":"ES Oh","year":"2019","unstructured":"Oh ES, Needham DM, Nikooie R, Wilson LM, Zhang A, Robinson KA, et al. Antipsychotics for preventing delirium in hospitalized adults: a systematic review. Ann Intern Med. 2019;171(7):474\u201384.","journal-title":"Ann Intern Med"},{"issue":"9","key":"8650_CR7","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s00134-021-06490-3","volume":"47","author":"LD Burry","year":"2021","unstructured":"Burry LD, Cheng W, Williamson DR, Adhikari NK, Egerod I, Kanji S, et al. Pharmacological and non-pharmacological interventions to prevent delirium in critically ill patients: a systematic review and network meta-analysis. Intensive Care Med. 2021;47(9):943\u201360.","journal-title":"Intensive Care Med"},{"issue":"9","key":"8650_CR8","doi-asserted-by":"publisher","first-page":"e825","DOI":"10.1097\/CCM.0000000000003299","volume":"46","author":"JW Devlin","year":"2018","unstructured":"Devlin JW, Skrobik Y, Gelinas C, Needham DM, Slooter AJC, Pandharipande PP, et al. Clinical practice guidelines for the prevention and management of pain, agitation\/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med. 2018;46(9):e825\u201373.","journal-title":"Crit Care Med"},{"key":"8650_CR9","doi-asserted-by":"crossref","unstructured":"American Geriatrics Society Expert Panel on Postoperative Delirium in Older A. American Geriatrics Society abstracted clinical practice guideline for postoperative delirium in older adults. J Am Geriatr Soc. 2015;63(1):142\u201350.","DOI":"10.1111\/jgs.13281"},{"issue":"9","key":"8650_CR10","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.001666","volume":"4","author":"M Sahlberg","year":"2015","unstructured":"Sahlberg M, Holm E, Gislason GH, Kober L, Torp-Pedersen C, Andersson C. Association of selected antipsychotic agents with major adverse cardiovascular events and noncardiovascular mortality in elderly persons. J Am Heart Assoc. 2015;4(9): e001666.","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"8650_CR11","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/gps.3999","volume":"29","author":"K Hatta","year":"2014","unstructured":"Hatta K, Kishi Y, Wada K, Odawara T, Takeuchi T, Shiganami T, et al. Antipsychotics for delirium in the general hospital setting in consecutive 2453 inpatients: a prospective observational study. Int J Geriatr Psychiatry. 2014;29(3):253\u201362.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"3","key":"8650_CR12","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1056\/NEJMoa0806994","volume":"360","author":"WA Ray","year":"2009","unstructured":"Ray WA, Chung CP, Murray KT, Hall K, Stein CM. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med. 2009;360(3):225\u201335.","journal-title":"N Engl J Med"},{"issue":"11","key":"8650_CR13","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1001\/jamaneurol.2020.2273","volume":"77","author":"TE Goldberg","year":"2020","unstructured":"Goldberg TE, Chen C, Wang Y, Jung E, Swanson A, Ing C, et al. Association of delirium with long-term cognitive decline: a meta-analysis. JAMA Neurol. 2020;77(11):1373\u201381.","journal-title":"JAMA Neurol"},{"issue":"4","key":"8650_CR14","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1093\/ageing\/afl005","volume":"35","author":"N Siddiqi","year":"2006","unstructured":"Siddiqi N, House AO, Holmes JD. Occurrence and outcome of delirium in medical in-patients: a systematic literature review. Age Ageing. 2006;35(4):350\u201364.","journal-title":"Age Ageing"},{"issue":"7","key":"8650_CR15","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1097\/CCM.0b013e3181e47be1","volume":"38","author":"TD Girard","year":"2010","unstructured":"Girard TD, Jackson JC, Pandharipande PP, Pun BT, Thompson JL, Shintani AK, et al. Delirium as a predictor of long-term cognitive impairment in survivors of critical illness. Crit Care Med. 2010;38(7):1513\u201320.","journal-title":"Crit Care Med"},{"issue":"1","key":"8650_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2165\/00002512-200118010-00004","volume":"18","author":"MJ Byerly","year":"2001","unstructured":"Byerly MJ, Weber MT, Brooks DL, Snow LR, Worley MA, Lescouflair E. Antipsychotic medications and the elderly. Drugs Aging. 2001;18(1):45\u201361.","journal-title":"Drugs Aging"},{"key":"8650_CR17","first-page":"117955731986381","volume":"10","author":"AR Levine","year":"2019","unstructured":"Levine AR, Lemieux SM, D\u2019Aquino D, Tenney A, Pisani M, Ali S. Risk factors for continuation of atypical antipsychotics at hospital discharge in two intensive care unit cohorts. Clinical Medicine Insights: Psychiatry. 2019;10:1179557319863813.","journal-title":"Clinical Medicine Insights: Psychiatry"},{"issue":"6","key":"8650_CR18","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.jcrc.2015.08.009","volume":"30","author":"AS Rowe","year":"2015","unstructured":"Rowe AS, Hamilton LA, Curtis RA, Davis CR, Smith LN, Peek GK, et al. Risk factors for discharge on a new antipsychotic medication after admission to an intensive care unit. J Crit Care. 2015;30(6):1283\u20136.","journal-title":"J Crit Care"},{"issue":"5","key":"8650_CR19","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1177\/0018578717750095","volume":"53","author":"GV Fontaine","year":"2018","unstructured":"Fontaine GV, Mortensen W, Guinto KM, Scott DM, Miller RR. Newly initiated in-hospital antipsychotics continued at discharge in non-psychiatric patients. Hosp Pharm. 2018;53(5):308\u201315.","journal-title":"Hosp Pharm"},{"issue":"3","key":"8650_CR20","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1177\/0897190012465987","volume":"26","author":"KD Jasiak","year":"2013","unstructured":"Jasiak KD, Middleton EA, Camamo JM, Erstad BL, Snyder LS, Huckleberry YC. Evaluation of discontinuation of atypical antipsychotics prescribed for ICU delirium. J Pharm Pract. 2013;26(3):253\u20136.","journal-title":"J Pharm Pract"},{"issue":"6","key":"8650_CR21","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/bcp.12732","volume":"80","author":"E Reeve","year":"2015","unstructured":"Reeve E, Gnjidic D, Long J, Hilmer S. A systematic review of the emerging de fi nition of \u201cdeprescribing\u201d with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol. 2015;80(6):1254\u201368.","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"8650_CR22","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/bcp.12386","volume":"78","author":"E Reeve","year":"2014","unstructured":"Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD. Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process. Br J Clin Pharmacol. 2014;78(4):738\u201347.","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"8650_CR23","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1111\/bcp.13394","volume":"83","author":"JK Aronson","year":"2017","unstructured":"Aronson JK, Ferner RE. Unlicensed and off-label uses of medicines: definitions and clarification of terminology. Br J Clin Pharmacol. 2017;83(12):2615\u201325.","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"8650_CR24","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.ccc.2018.06.009","volume":"34","author":"TD Girard","year":"2018","unstructured":"Girard TD. Sedation, delirium, and cognitive function after critical illness. Crit Care Clin. 2018;34(4):585\u201398.","journal-title":"Crit Care Clin"},{"issue":"10","key":"8650_CR25","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1097\/CCM.0000000000002103","volume":"44","author":"JW Devlin","year":"2016","unstructured":"Devlin JW, Smithburger P, Kane JM, Fraser GL, Skrobik Y. Intended and unintended consequences of constraining clinician prescribing: the case of antipsychotics. Crit Care Med. 2016;44(10):1805\u20137.","journal-title":"Crit Care Med"},{"issue":"4","key":"8650_CR26","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1177\/0269881114562090","volume":"29","author":"SL Young","year":"2015","unstructured":"Young SL, Taylor M, Lawrie SM. \u201cFirst do no harm.\u201d\u00a0 A systematic review of the prevalence and management of antipsychotic adverse effects. J Psychopharmacol. 2015;29(4):353\u201362.","journal-title":"J Psychopharmacol"},{"key":"8650_CR27","doi-asserted-by":"crossref","unstructured":"Peters MDJ GC, McInerney P, Munn Z, Tricco AC, Khalil, H. Chapter 11: Scoping Reviews (2020 version). 2020. In: JBI Manual for Evidence Synthesis, JBI [Internet]. Available from: https:\/\/synthesismanual.jbi.global.","DOI":"10.46658\/JBIMES-20-12"},{"issue":"1","key":"8650_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/1364557032000119616","volume":"8","author":"H Arksey","year":"2005","unstructured":"Arksey H, O\u2019Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19\u201332.","journal-title":"Int J Soc Res Methodol"},{"issue":"6","key":"8650_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-057585","volume":"12","author":"N Jaworska","year":"2022","unstructured":"Jaworska N, Moss SJ, Krewulak KD, Stelfox Z, Niven D, Ismail Z, et al. Antipsychotic prescribing practices and patient, family member and healthcare professional perceptions of antipsychotic prescribing in acute care settings: a scoping review protocol. BMJ Open. 2022;12(6): e057585.","journal-title":"BMJ Open"},{"issue":"7","key":"8650_CR30","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018;169(7):467\u201373.","journal-title":"Ann Intern Med"},{"issue":"3","key":"8650_CR31","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1213\/ANE.0000000000005365","volume":"133","author":"CS Boncyk","year":"2021","unstructured":"Boncyk CS, Farrin E, Stollings JL, Rumbaugh K, Wilson JE, Marshall M, et al. Pharmacologic management of intensive care unit delirium: clinical prescribing practices and outcomes in more than 8500 patient encounters. Anesth Analg. 2021;133(3):713\u201322.","journal-title":"Anesth Analg"},{"issue":"1","key":"8650_CR32","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1186\/s13054-016-1557-1","volume":"20","author":"JE Tomichek","year":"2016","unstructured":"Tomichek JE, Stollings JL, Pandharipande PP, Chandrasekhar R, Ely EW, Girard TD. Antipsychotic prescribing patterns during and after critical illness: a prospective cohort study. Crit Care. 2016;20(1):378.","journal-title":"Crit Care"},{"key":"8650_CR33","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jcrc.2015.12.017","volume":"33","author":"J Marshall","year":"2016","unstructured":"Marshall J, Herzig SJ, Howell MD, Le SH, Mathew C, Kats JS, et al. Antipsychotic utilization in the intensive care unit and in transitions of care. J Crit Care. 2016;33:119\u201324.","journal-title":"J Crit Care"},{"key":"8650_CR34","doi-asserted-by":"crossref","unstructured":"Serafim RB, Bozza FA, Soares M, do Brasil PE, Tura BR, Ely EW, et al. Pharmacologic prevention and treatment of delirium in intensive care patients: A systematic review. J Crit Care. 2015;30(4):799\u2013807.","DOI":"10.1016\/j.jcrc.2015.04.005"},{"key":"8650_CR35","doi-asserted-by":"crossref","unstructured":"Burry L, Mehta S, Perreault MM, Luxenberg JS, Siddiqi N, Hutton B, et al. Antipsychotics for treatment of delirium in hospitalised non\u2010ICU patients. Cochrane Database of Systematic Reviews. 2018(6).","DOI":"10.1002\/14651858.CD005594.pub3"},{"issue":"3","key":"8650_CR36","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3163\/1536-5050.104.3.014","volume":"104","author":"WM Bramer","year":"2016","unstructured":"Bramer WM, Giustini D, de Jonge GB, Holland L, Bekhuis T. De-duplication of database search results for systematic reviews in EndNote. J Med Libr Assoc. 2016;104(3):240\u20133.","journal-title":"J Med Libr Assoc"},{"issue":"9","key":"8650_CR37","doi-asserted-by":"publisher","first-page":"677","DOI":"10.7326\/M19-0891","volume":"171","author":"JL Jackson","year":"2019","unstructured":"Jackson JL, Kuriyama A, Anton A, Choi A, Fournier J-P, Geier A-K, et al. The accuracy of google translate for abstracting data from non\u2013english-language trials for systematic reviews. Ann Intern Med. 2019;171(9):677\u20139.","journal-title":"Ann Intern Med"},{"issue":"1","key":"8650_CR38","first-page":"26","volume":"5","author":"VMA Milam","year":"2020","unstructured":"Milam VMA. A Comparison of free online machine language translators. Journal of Management Science and Business Intelligence. 2020;5(1):26\u201331.","journal-title":"Journal of Management Science and Business Intelligence"},{"issue":"1","key":"8650_CR39","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13012-017-0605-9","volume":"12","author":"L Atkins","year":"2017","unstructured":"Atkins L, Francis J, Islam R, O\u2019Connor D, Patey A, Ivers N, et al. A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems. Implement Sci. 2017;12(1):77.","journal-title":"Implement Sci"},{"issue":"1","key":"8650_CR40","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1136\/qshc.2004.011155","volume":"14","author":"S Michie","year":"2005","unstructured":"Michie S, Johnston M, Abraham C, Lawton R, Parker D, Walker A, et al. Making psychological theory useful for implementing evidence based practice: a consensus approach. Qual Saf Health Care. 2005;14(1):26\u201333.","journal-title":"Qual Saf Health Care"},{"issue":"2","key":"8650_CR41","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77\u2013101.","journal-title":"Qual Res Psychol"},{"issue":"7","key":"8650_CR42","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S2213-2600(13)70166-8","volume":"1","author":"VJ Page","year":"2013","unstructured":"Page VJ, Ely EW, Gates S, Zhao XB, Alce T, Shintani A, et al. Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial. Lancet Respir Med. 2013;1(7):515\u201323.","journal-title":"Lancet Respir Med"},{"key":"8650_CR43","doi-asserted-by":"crossref","unstructured":"Correll CU, Schenk EM. Tardive dyskinesia and new antipsychotics. Current Opinion in Psychiatry. 2008;21(2).","DOI":"10.1097\/YCO.0b013e3282f53132"},{"issue":"12","key":"8650_CR44","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1001\/archpsyc.58.12.1161","volume":"58","author":"WA Ray","year":"2001","unstructured":"Ray WA, Meredith S, Thapa PB, Meador KG, Hall K, Murray KT. Antipsychotics and the risk of sudden cardiac death. Arch Gen Psychiatry. 2001;58(12):1161\u20137.","journal-title":"Arch Gen Psychiatry"},{"key":"8650_CR45","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jcrc.2019.01.009","volume":"50","author":"Y Zayed","year":"2019","unstructured":"Zayed Y, Barbarawi M, Kheiri B, Banifadel M, Haykal T, Chahine A, et al. Haloperidol for the management of delirium in adult intensive care unit patients: a systematic review and meta-analysis of randomized controlled trials. J Crit Care. 2019;50:280\u20136.","journal-title":"J Crit Care"},{"issue":"3","key":"8650_CR46","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00213-003-1759-5","volume":"174","author":"S Cohrs","year":"2004","unstructured":"Cohrs S, Rodenbeck A, Guan Z, Pohlmann K, Jordan W, Meier A, et al. Sleep-promoting properties of quetiapine in healthy subjects. Psychopharmacology. 2004;174(3):421\u20139.","journal-title":"Psychopharmacology"},{"issue":"4","key":"8650_CR47","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1177\/0897190018761412","volume":"32","author":"BL Kram","year":"2019","unstructured":"Kram BL, Schultheis JM, Kram SJ, Cox CE. A pharmacy-based electronic handoff tool to reduce discharge prescribing of atypical antipsychotics initiated in the intensive care unit: a quality improvement initiative. J Pharm Pract. 2019;32(4):434\u201341.","journal-title":"J Pharm Pract"},{"issue":"1","key":"8650_CR48","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1177\/0885066616686741","volume":"34","author":"RG D'Angelo","year":"2019","unstructured":"D\u2019Angelo RG, Rincavage M, Tata AL, Millstein LS, Gulati MS, Flurie RW, et al. Impact of an antipsychotic discontinuation bundle during transitions of care in critically ill patients. J Intensive Care Med. 2019;34(1):40\u20137.","journal-title":"J Intensive Care Med"},{"issue":"6","key":"8650_CR49","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1002\/jac5.1234","volume":"3","author":"MM Stuart","year":"2020","unstructured":"Stuart MM, Smith ZR, Payter KA, Martz CR, To L, Swiderek JL, et al. Pharmacist-driven discontinuation of antipsychotics for ICU delirium: a quasi-experimental study. JACCP Journal of the American College of Clinical Pharmacy. 2020;3(6):1009\u201314.","journal-title":"JACCP Journal of the American College of Clinical Pharmacy"},{"issue":"3\u20134","key":"8650_CR50","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1503\/cmaj.081229","volume":"181","author":"SE Straus","year":"2009","unstructured":"Straus SE, Tetroe J, Graham I. Defining knowledge translation. CMAJ. 2009;181(3\u20134):165\u20138.","journal-title":"CMAJ"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-022-08650-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-022-08650-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-022-08650-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T15:08:05Z","timestamp":1666451285000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-022-08650-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,21]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["8650"],"URL":"https:\/\/doi.org\/10.1186\/s12913-022-08650-7","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,21]]},"assertion":[{"value":"28 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There are no declared competing interests from any of the contributing authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1272"}}